3-(4-chlorophenyl)-3-acetamido-N-[2-methyl-2-(morpholin-4-yl)propyl]propanamide
Structure Info
- Chemspace ID
- CSSS00026869353 (In-Stock Screening Compounds)
- CAS
- 1210495-37-6
- IUPAC Name
- 3-(4-chlorophenyl)-3-acetamido-N-[2-methyl-2-(morpholin-4-yl)propyl]propanamide
- Mol formula
- C19H28ClN3O3
- Mol weight
- 382 Da
- Catalog Number(s)
- CSC026869353, CSCR00472295228, PB87724270, Z87646802, s_1626____22011922____511712
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.21
- Heavy atoms count
- 26
- Rotatable bond count
- 7
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.578
- Polar surface area (Å)
- 71
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 2
![Chemical structure of 3-(4-chlorophenyl)-3-acetamido-N-[2-methyl-2-(morpholin-4-yl)propyl]propanamide (C19H28ClN3O3) - CSSS00026869353](/st/structure/200/ab31090ca34c645a7f9eb5b90d14ac65/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529NCC%2528C%2529%2528C%2529N1CCOCC1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png "C19H28ClN3O3")
- Zoom the structure
- CSSS00026869353
Items Overall 10 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 1 mg | 74.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 2 mg | 76.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 5 mg | 82.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 10 mg | 92.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 90 | 20 mg | 111.00 | |
| UORSY | 5 days | Ukraine To: | 90 | 1 mg | 74.00 | |
| UORSY | 5 days | Ukraine To: | 90 | 2 mg | 76.00 | |
| UORSY | 5 days | Ukraine To: | 90 | 5 mg | 82.00 | |
| UORSY | 5 days | Ukraine To: | 90 | 10 mg | 92.00 | |
| UORSY | 5 days | Ukraine To: | 90 | 20 mg | 111.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 3-acetamido-N-[2-methyl-2-(morpholin-4-yl)propyl]-3-phenylpropanamide - CSSS00026292874](/st/structure/200/b2af99a1497ebbd7750909bc443436ce/CC%2528%253DO%2529NC%2528CC%2528%253DO%2529NCC%2528C%2529%2528C%2529N1CCOCC1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[2-methyl-2-(morpholin-4-yl)propyl]-3,3-diphenylpropanamide - CSSS00105994742](/st/structure/200/0a76d67901f12ebb77ad382b99642b59/CC%2528C%2529%2528CNC%2528%253DO%2529CC%2528C1%253DCC%253DCC%253DC1%2529C1%253DCC%253DCC%253DC1%2529N1CCOCC1.png)
![Chemical structure of 2-[(4-chlorophenyl)sulfanyl]-N-[2-methyl-2-(morpholin-4-yl)propyl]acetamide - CSSS00026292442](/st/structure/200/1b4fa4b81db3da0a8491e2d4eef8d747/CC%2528C%2529%2528CNC%2528%253DO%2529CSC1%253DCC%253DC%2528Cl%2529C%253DC1%2529N1CCOCC1.png)
![Chemical structure of 3-(4-chlorophenoxy)-N-[2-methyl-2-(morpholin-4-yl)propyl]propanamide - CSSS00025956867](/st/structure/200/380511a75bd82a1ee33c0133d3110d37/CC%2528C%2529%2528CNC%2528%253DO%2529CCOC1%253DCC%253DC%2528Cl%2529C%253DC1%2529N1CCOCC1.png)
![Chemical structure of 2-(4-chlorophenoxy)-N-[2-methyl-2-(morpholin-4-yl)propyl]acetamide - CSSS00026445477](/st/structure/200/a1a6291060532e2fe8d91a39fc70c274/CC%2528C%2529%2528CNC%2528%253DO%2529COC1%253DCC%253DC%2528Cl%2529C%253DC1%2529N1CCOCC1.png)
![Chemical structure of 2-[(4-chlorophenyl)formamido]-N-[2-methyl-2-(morpholin-4-yl)propyl]acetamide - CSSS00026445436](/st/structure/200/7d19bb67005e92b7539de2b39318608b/CC%2528C%2529%2528CNC%2528%253DO%2529CNC%2528%253DO%2529C1%253DCC%253DC%2528Cl%2529C%253DC1%2529N1CCOCC1.png)
![Chemical structure of 2-(4-chlorophenyl)-N-[2-methyl-2-(morpholin-4-yl)propyl]acetamide - CSSS00026445476](/st/structure/200/069a51449815036c3b48fd5b84dd7610/CC%2528C%2529%2528CNC%2528%253DO%2529CC1%253DCC%253DC%2528Cl%2529C%253DC1%2529N1CCOCC1.png)
